ABBV (AbbVie) Shiller PE Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ABBV AbbVie Inc ABBV
76 GF Score
Price $263.96
GF Value $220.80
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is AbbVie Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


AbbVie  (NYSE:ABBV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AbbVie Shiller PE Ratio Related Terms


AbbVie Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for AbbVie's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AbbVie Shiller PE Ratio Chart

AbbVie Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 34.53 36.70 34.54 37.75 49.23

AbbVie Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.86 49.07 48.78 46.31 52.24

ABBV vs MRK, JNJ, AMGN: Shiller PE Ratio Comparison

For the Drug Manufacturers - General subindustry, AbbVie's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AbbVie Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AbbVie's Shiller PE Ratio falls into.


ABBV
76GF Score
AbbVie Inc ABBV
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AbbVie Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AbbVie's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, AbbVie's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.0333/333.9520*333.9520
=2.033

Current CPI (Jun. 2026) = 333.9520.

AbbVie Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.970 241.428 1.342
201612 0.850 241.432 1.176
201703 1.060 243.801 1.452
201706 1.190 244.955 1.622
201709 1.010 246.819 1.367
201712 0.030 246.524 0.041
201803 1.740 249.554 2.328
201806 1.260 251.989 1.670
201809 1.810 252.439 2.394
201812 -1.230 251.233 -1.635
201903 1.650 254.202 2.168
201906 0.490 256.143 0.639
201909 1.264 256.759 1.643
201912 1.877 256.974 2.440
202003 2.019 258.115 2.612
202006 -0.459 257.797 -0.595
202009 1.291 260.280 1.657
202012 0.011 260.474 0.014
202103 1.988 264.877 2.507
202106 0.422 271.696 0.518
202109 1.777 274.310 2.164
202112 2.263 278.802 2.710
202203 2.513 287.504 2.919
202206 0.514 296.311 0.579
202209 2.213 296.808 2.490
202212 1.391 296.797 1.565
202303 0.128 301.836 0.142
202306 1.137 305.109 1.244
202309 0.998 307.789 1.083
202312 0.458 306.746 0.498
202403 0.767 312.332 0.820
202406 0.768 314.175 0.816
202409 0.875 315.301 0.927
202412 -0.018 315.605 -0.019
202503 0.720 319.799 0.752
202506 0.524 322.561 0.543
202509 0.099 324.800 0.102
202512 1.018 324.054 1.049
202603 0.386 330.213 0.390
202606 2.033 333.952 2.033

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is AbbVie (ABBV) Overvalued in 2026?

Based on GuruFocus' analysis, AbbVie stock appears to be overvalued. The current stock price of $263.96 is trading 19.5% above its estimated GF Value™ of $220.80. GuruFocus considers AbbVie to be Modestly Overvalued.

Key valuation signals for ABBV:

  • Shiller PE Ratio:
  • GF Value™: $220.80 vs. price of $263.96 (19.5% above fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the ABBV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AbbVie Business Description

Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
76GF Score

Get the complete analysis for ABBV

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$263.96
Price
$220.80
GF Value